OracleORCLTOP PICKDec 31, 2024Stock price when the opinion was issued
As of Sep 15, 2026. Market Open.
They just reported: 30% topline revenue growth, free cash flow a lot better than expected, though still negative because they're investing in the business. They did not announce new capex plans. Their current default swaps are starting to make a difference, from 215 bps a few weeks ago, and now at 181 bps. Lots to like, but shares are down because interest rates are up in recent days. You can buy on weakness now. Their capex spend will remain an overhang, though.
Hyperscaler. Ran into issues with a series of announcements that amounted to running up a bill of $80B. So then they had to get financing and raise $20B in stock issuance. Reports next week. Price target of $258, and you won't find a much longer runway. Yield is 1.35%.
(Analysts’ price target is $245.49)Generated $32B of operating cashflow last year. FCF is negative because they spent roughly $56B building AI data centres. Investors are willing to tolerate that spending because of extraordinary demand. Wouldn't expect a FCF reversal while the buildout continues, but those new data centres will produce revenue.
Rebound potential. Wait and see, earnings next week. She has only a 1/2 position now, and will see what the earnings report says.
He targets $207.35. Operates three segments, including cloud. A great turnaround story to get into the cloud, now #4. They reported Nov. 5 and missed top and bottom lines. Shares traded off, but others snapped up those shares. They recently did a big partnership with Meta. The forward PE is an attractive 31x. Has 15% upside.
(Analysts’ price target is $197.84)